Gain Therapeutics GANX
NASDAQ GANX
$2.04 +0.06 (+3.03%)
As of: Aug 21, 2026 · 11:07 AM EDT

Gain Therapeutics (GANX) Pension (2020 - 2026)

Gain Therapeutics (GANX) posted quarterly Pension of $389519.0 for Q1 2026, down 17.27% year-over-year from $470856.0 in Q1 2025, and little changed quarter-over-quarter from $390509.0 in Q4 2025.

Gain Therapeutics (GANX) Pension (2020 - 2026) Analysis & Trends

Gain Therapeutics' Pension history runs 7 years deep, the most recent figure standing at $389519.0 for Q1 2026.

  • In Q1 2026, Pension fell 17.27% year-over-year to $389519.0; the TTM figure through Mar 2026 stood at $389519.0 (down 17.27% YoY), while the FY2025 annual figure was $390509.0, down 11.97% from the prior year.
  • Pension for Q1 2026 stood at $389519.0, roughly flat from $390509.0 in the prior quarter.
  • The five-year high for Pension was $527825.0 in Q3 2025, with the low at $157580.0 in Q4 2022.
  • The 5-year median for Pension is $367434.0 (2022), against an average of $337941.1.
  • The sharpest annual moves came in 2023 and 2024: Pension tumbled 57.51% in 2023, then surged 101.4% in 2024.
  • Gain Therapeutics' Pension stood at $157580.0 in 2022, then surged by 95.11% to $307454.0 in 2023, then soared by 44.29% to $443623.0 in 2024, then declined by 11.97% to $390509.0 in 2025, then decreased by 0.25% to $389519.0 in 2026.
  • Business Quant data shows GANX's Pension at $389519.0 in Q1 2026, $390509.0 in Q4 2025, and $527825.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.23 Bn 132.38 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.97 Bn 78.97 Bn 3.93 Bn
3 Argenx Se 65.29 Bn 60.11 Bn 1.37 Bn
4 Moderna 59.88 Bn 54.74 Bn 52.00 Mn
5 BeOne Medicines 42.20 Bn 37.11 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.62 Bn 28.31 Bn 992.69 Mn
7 BioNTech SE 28.69 Bn 10.30 Bn 668.28 Mn
8 Insmed 27.51 Bn 26.35 Bn 358.27 Mn
9 Royalty Pharma 27.16 Bn 26.33 Bn -
10 Gain Therapeutics 87.47 Mn 87.47 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 319,225.00
Mar 31, 2026 389,519.00
Dec 31, 2025 390,509.00
Sep 30, 2025 527,825.00
Jun 30, 2025 522,676.00
Mar 31, 2025 470,856.00
Dec 31, 2024 443,623.00
Sep 30, 2024 323,266.00
Jun 30, 2024 298,428.00
Mar 31, 2024 292,486.00
Dec 31, 2023 307,454.00
Sep 30, 2023 160,512.00
Jun 30, 2023 174,185.00
Mar 31, 2023 164,568.00
Dec 31, 2022 157,580.00
Sep 30, 2022 377,782.00
Jun 30, 2022 376,295.00
Mar 31, 2022 367,434.00
Dec 31, 2021 329,458.00
Sep 30, 2021 243,612.00